Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. United Kingdom
  4. London Stock Exchange
  5. PureTech Health plc
  6. Summary
    PRTC   GB00BY2Z0H74

PURETECH HEALTH PLC

(PRTC)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed London Stock Exchange
07/26/2021 07/27/2021 07/28/2021 07/29/2021 07/30/2021 Date
337.5(c) 337(c) 329.5(c) 322.5(c) 321.5(c) Last
83 970 159 725 336 752 124 983 146 515 Volume
-2.03% -0.15% -2.23% -2.12% -0.31% Change
More quotes
Estimated financial data (e) (USD)
Sales 2021 11,2 M - -
Net income 2021 -131 M - -
Net cash position 2021 424 M - -
P/E ratio 2021 -10,2x
Yield 2021 -
Sales 2022 9,08 M - -
Net income 2022 -147 M - -
Net cash position 2022 329 M - -
P/E ratio 2022 -9,71x
Yield 2022 -
Capitalization 1 280 M 1 281 M -
EV / Sales 2021 76,6x
EV / Sales 2022 105x
Nbr of Employees 250
Free-Float 84,3%
More Financials
Company
PureTech Health PLC is a clinical stage biotechnology company. The Company is engaged in discovering, developing and commercializing medicines for diseases, including intractable cancers, lymphatic and gastrointestinal diseases, central nervous system disorders, and inflammatory and immunological diseases, among others. Its segments include Internal and Affiliates. The Internal division is focused on advancing a... 
More about the company
Ratings of PureTech Health plc
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
C-
More Ratings
All news about PURETECH HEALTH PLC
07/22PURETECH HEALTH : Founded Entity Akili Releases New Gameplay Features in the Fir..
BU
07/21PURETECH HEALTH : Founded Entity Vedanta Biosciences Completes $68 Million Serie..
BU
07/19PURETECH HEALTH : Weight management firm Gelesis to list on NYSE via SPAC deal
RE
07/19PURETECH HEALTH : Gelesis to List on NYSE Through Merger With SPAC
MT
07/19CAPSTAR SPECIAL PURPOSE ACQUISITION : PureTech's Gelesis to Merge With SPAC Caps..
MT
07/19PURETECH HEALTH : Weight management firm Gelesis to list on NYSE via SPAC deal
RE
07/19PURETECH HEALTH : Founded Entity Gelesis, the Maker of Plenity®, to Become a Pub..
PU
07/19PURETECH HEALTH : Founded Entity Gelesis, the Maker of Plenity®, to Become a Pub..
BU
07/09Vor Biopharma Collaborating With Janssen to Develop Potential Treatment for A..
MT
07/09PURETECH HEALTH : Founded Entity Vor Biopharma Announces Collaboration with Jans..
BU
07/09Vor Biopharma Working With Janssen Biotech on Leukemia Treatment
DJ
07/08PURETECH HEALTH : Founded Entity Sonde Health Announces Collaboration with Qualc..
BU
07/07PURETECH HEALTH : Enters Clinical Trial, Supply Deal With BeiGene Affiliate to T..
MT
07/07PURETECH HEALTH : Announces Clinical Trial and Supply Agreement with BeiGene to ..
BU
07/07PureTech Announces Clinical Trial and Supply Agreement with BeiGene to Evalua..
CI
More news
News in other languages on PURETECH HEALTH PLC
04/16STOCK MARKET PARIS : La croissance chinoise s'invite chez les sorcières
04/16AVIS D'ANALYSTES DU JOUR : Safran, Publicis, Nestlé, Volkswagen, Siemens, Givaud..
2020AVIS D'ANALYSTES DU JOUR : BNP Paribas, LVMH, L'Oréal, Vallourec, Nexans, Sunris..
2020STOCK MARKET PARIS : Coronavirus, peur sur l'économie
2018ERRATA CORRIGE : Pubblicati sulla rivista Obesity i dati principali sulla perdit..
More news
Analyst Recommendations on PURETECH HEALTH PLC
More recommendations
Chart PURETECH HEALTH PLC
Duration : Period :
PureTech Health plc Technical Analysis Chart | PRTC | GB00BY2Z0H74 | MarketScreener
Technical analysis trends PURETECH HEALTH PLC
Short TermMid-TermLong Term
TrendsBearishBearishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 3
Last Close Price 4,47 $
Average target price 9,09 $
Spread / Average Target 103%
EPS Revisions
Managers and Directors
Daphne Zohar Chief Executive Officer & Executive Director
Bharatt M. Chowrira President, Secretary & Executive Director
George Farmer Chief Financial Officer
Christopher A. Viehbacher Chairman
Joseph B. Bolen Chief Scientific Officer
Sector and Competitors
1st jan.Capi. (M$)
PURETECH HEALTH PLC-19.63%1 281
MODERNA, INC.238.47%141 980
LONZA GROUP AG23.98%57 809
IQVIA HOLDINGS INC.38.25%47 462
CELLTRION, INC.-29.39%30 059
SEAGEN INC.-12.42%27 837